G. Grant Welstead, et al. Characterization of Cas9-mediated genome editing in human T cells. Presented at the 18th Annual American Society of Gene & Cell Therapy (ASGCT) Meeting, May 14, 2015.

Aug

30

Editas Medicine Announces Upcoming Investor Events

Aug

2

Editas Medicine Announces Second Quarter 2023 Results and Business Updates

Jul

27

Editas Medicine and Azzur Group Expand Partnership to Accelerate Editas’ Manufacturing Capabilities for Advancing the EDIT-301 Program Through Approval to Commercialization